title: Limitations of targeted therapy with sorafenib in elderly high-risk myelodysplastic syndrome and acute myeloid leukemia.
authors.affiliation: Department of Clinical Hematology, The Alfred Hospital, Melbourne, Australia. a.wei@alfred.org.au
authors.forename: Andrew
authors.initials: A
authors.lastname: Wei
authors.forename: Peter
authors.initials: P
authors.lastname: Tan
mesh_terms: D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D009536:Niacinamide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000008:administration & dosage*; D000077157:Sorafenib
chemical_list: D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib